115 CMR 10.07
Consent Procedures
(1) The consent procedure set out in 115 CMR 10.07 is applicable to all research. The content of
the written consent form and the manner in which such consent will be sought shall be part of the
Committee's review of the research proposal.
(2) The consent formmust be written in language understandable to the participant and the guardian,
if applicable. The form may not include any waiver of a participant's rights or any exculpatory language
absolving the investigator, the sponsor, the Department, the program or their agents from liability for
research-related injury. The form must provide the following information to each prospective
participant and their guardian, if applicable:
(a) a statement that the study involves research, what is expected of the participant, with a full
explanation of the purposes and objectives of the research;
(b) the basis for selection of the participant and the expected duration of the individual's
participation;
(c) a description of the procedures to be followed and the identification of any procedures which
are experimental;
(d)
a description of any reasonably foreseeable risks or discomforts to the participant, their
expected severity and duration;
(e) a description of any benefits to the participant or others which may reasonably be expected
from the research;
(f) a statement describing how confidentiality of records and privacy of participants will be
maintained;
(g) a descriptionofanyappropriate alternative procedures or courses of treatment that could be
used in lieu of the experimental procedure, or if there is no alternative procedure;
(h) an offer to answer any questions concerning the procedures and the participant's rights and
a statement of whom to contact and how for further information;
(i) a statement that participation is voluntary and the individual shall be informed, bothverbally and
in writing, that he or she is free to withhold consent or to withdraw consent and to discontinue
participation in the research at any time without penalty or loss of benefits, services or supports
which the individual is otherwise receiving;
(j) if the prospective participant is an individual receiving services provided or purchased by the
Department or a family member of such an individual, a statement that the provision of such
services to the individualdo not depend on participation by the individual or family member in the
research;
(k) where applicable, a description of any controlled substance as defined in the Massachusetts
Department of Public Health regulations implementing M.G.L. c. 94, and any other substances to
be used, and their anticipated effects, side effects and interactions. The description must be in
language understandable to the prospective participant or guardian.
(3) A copy of the consent form, as approved by the Committee, must be given to each participant and
his or her guardian, if applicable. The Committee may require a witness to be present at the time
consent is sought, unless 115 CMR 10.08(2): Additional Requirements, applies.
(4) Notwithstanding the consent of the guardian, an individual's participation in a researchprojectmust
cease if the individual objects, by verbal or nonverbal means, to participation.
(5) The Committee may approve a modified consent form, but only if it finds and documents that all
of the conditions listed in 115 CMR 10.07(5)(a) through (c) are met.
(a) The proposed research involves no more than minimalrisk of social, psychological, or physical
harm to the participant;
(b) A full explanation of the purpose(s) or objective(s) of the research before its completion
would compromise or invalidate the study;
(c) The consent form provides the following information to each prospective participant and their
guardian, if applicable:
1. a statement that the study involves research;
2. a general description of the nature of the research;
3. a statement that some aspects of the research purpose(s) or objectives are being withheld
from the participant;
4. a statement that after the individual's participation in the research, the participant will be
provided a written full explanation of the research purpose(s) and objective(s);
5. a statement that the individual agrees to participate in the research in the absence of a full
explanation of the purpose(s) and objective(s) of the research study.
(6) The consent procedures described in 115 CMR 10.07(1) through 10.07(5) do not apply to a
researchproject involving access to private information, but only if the Committee finds anddocuments
that:
(a) the research consists of the study of historical records, and the researcher presents plans to
protect the confidentiality of the information and to preclude the identification of particular
individuals; or,
(b) the researchconsists of a review of records for the sole purpose of extractinginformationfor
a demographic or statistical study in which no person can be identified.
(7) Where a research investigator wishes to utilize the consent procedure described in 115 CMR
10.07(5) or (6), he or she must submit to the Committee, as part of the research proposal submission,
specific and detailed reasons for seeking such consent procedure. The Committee may impose such
conditions as it deems appropriate to safeguard the rights and welfare of the participants. Such
conditions may include the appointment of advocates and monitors and stringent procedures to protect
the confidentiality of personal information.